| Product Code: ETC9560608 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Non-Invasive Cancer Diagnostics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Non-Invasive Cancer Diagnostics Market - Industry Life Cycle |
3.4 Sweden Non-Invasive Cancer Diagnostics Market - Porter's Five Forces |
3.5 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Sweden Non-Invasive Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of non-invasive cancer diagnostics in Sweden |
4.2.2 Technological advancements leading to more accurate and efficient diagnostic tools |
4.2.3 Growing prevalence of cancer cases in Sweden |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for non-invasive cancer diagnostics |
4.3.2 Regulatory hurdles and compliance requirements for introducing new diagnostic tools in the market |
5 Sweden Non-Invasive Cancer Diagnostics Market Trends |
6 Sweden Non-Invasive Cancer Diagnostics Market, By Types |
6.1 Sweden Non-Invasive Cancer Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Urine Test, 2021- 2031F |
6.1.4 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.1.5 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Spectroscopy, 2021- 2031F |
6.2 Sweden Non-Invasive Cancer Diagnostics Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.5 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.6 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.7 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Non-Invasive Cancer Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ambulatory Care, 2021- 2031F |
6.3.4 Sweden Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Non-Invasive Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Sweden Non-Invasive Cancer Diagnostics Market Export to Major Countries |
7.2 Sweden Non-Invasive Cancer Diagnostics Market Imports from Major Countries |
8 Sweden Non-Invasive Cancer Diagnostics Market Key Performance Indicators |
8.1 Average time to diagnosis for patients using non-invasive cancer diagnostics |
8.2 Adoption rate of non-invasive cancer diagnostic tests by healthcare providers |
8.3 Number of research studies and publications supporting the efficacy of non-invasive cancer diagnostics in Sweden |
9 Sweden Non-Invasive Cancer Diagnostics Market - Opportunity Assessment |
9.1 Sweden Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Sweden Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Sweden Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Sweden Non-Invasive Cancer Diagnostics Market - Competitive Landscape |
10.1 Sweden Non-Invasive Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Non-Invasive Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here